187 related articles for article (PubMed ID: 29522099)
1. The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents.
Khan N; Trivedi C; Shah Y; Patel D; Lewis J; Yang YX
Inflamm Bowel Dis; 2018 May; 24(6):1274-1279. PubMed ID: 29522099
[TBL] [Abstract][Full Text] [Related]
2. Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.
Khan N; Patel D; Trivedi C; Shah Y; Lichtenstein G; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1919-1927.e3. PubMed ID: 29309905
[TBL] [Abstract][Full Text] [Related]
3. Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications.
Khan N; Shah Y; Trivedi C; Lewis JD
Aliment Pharmacol Ther; 2017 Oct; 46(7):668-672. PubMed ID: 28805309
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.
Long MD; Martin C; Sandler RS; Kappelman MD
Aliment Pharmacol Ther; 2013 Feb; 37(4):420-9. PubMed ID: 23240738
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Herpes Zoster Vaccination Among Inflammatory Bowel Disease Patients.
Khan N; Trivedi C; Kavani H; Lewis J; Yang YX
Inflamm Bowel Dis; 2019 Jan; 25(2):345-351. PubMed ID: 29982646
[TBL] [Abstract][Full Text] [Related]
6. Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
Santella C; Bitton A; Filliter C; Bessissow T; Vutcovici M; Lakatos PL; Brassard P
Inflamm Bowel Dis; 2022 Feb; 28(2):176-182. PubMed ID: 33999136
[TBL] [Abstract][Full Text] [Related]
7. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
Liao TL; Chen YM; Liu HJ; Chen DY
BMJ Open; 2017 Jan; 7(1):e014032. PubMed ID: 28057661
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors.
Segan J; Staples MP; March L; Lassere M; Chakravarty EF; Buchbinder R
Intern Med J; 2015 Mar; 45(3):310-8. PubMed ID: 25565419
[TBL] [Abstract][Full Text] [Related]
9. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
Beigel F; Steinborn A; Schnitzler F; Tillack C; Breiteneicher S; John JM; Van Steen K; Laubender RP; Göke B; Seiderer J; Brand S; Ochsenkühn T
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):735-44. PubMed ID: 24788825
[TBL] [Abstract][Full Text] [Related]
10. Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
Khan N; Trivedi C; Aberra F; Pernes T; Yang YX
J Crohns Colitis; 2022 Sep; 16(9):1505-1507. PubMed ID: 35350070
[TBL] [Abstract][Full Text] [Related]
11. Repeated Occurrences of Basal Cell Cancer in Patients With Inflammatory Bowel Disease Treated With Immunosuppressive Medications.
Khan N; Patel D; Trivedi C; Kavani H; Medvedeva E; Pernes T; Xie D; Lewis J; Yang YX
Am J Gastroenterol; 2020 Aug; 115(8):1246-1252. PubMed ID: 32453047
[TBL] [Abstract][Full Text] [Related]
12. Mortality Associated With Development of Squamous Cell Cancer in Patients With Inflammatory Bowel Diseases Receiving Treatment With Thiopurines.
Khan N; Lee H; Trivedi C; Kavani H; Medvedeva E; Xie D; Lewis JD; Yang YX
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2262-2268. PubMed ID: 30853615
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists.
Shah R; Ho EY; Kramer JR; Richardson P; Sansgiry S; El-Serag HB; Hou JK
Dig Dis Sci; 2018 Jun; 63(6):1551-1557. PubMed ID: 29663266
[TBL] [Abstract][Full Text] [Related]
14. Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease.
Nyboe Andersen N; Pasternak B; Basit S; Andersson M; Svanström H; Caspersen S; Munkholm P; Hviid A; Jess T
JAMA; 2014 Jun; 311(23):2406-13. PubMed ID: 24938563
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease.
Lobatón T; Ferrante M; Rutgeerts P; Ballet V; Van Assche G; Vermeire S
Aliment Pharmacol Ther; 2015 Aug; 42(4):441-51. PubMed ID: 26104047
[TBL] [Abstract][Full Text] [Related]
16. Psoriatic arthritis treatment and the risk of herpes zoster.
Zisman D; Bitterman H; Shalom G; Feldhamer I; Comanesther D; Batat E; Greenberg-Dotan S; Cohen S; Cohen AD
Ann Rheum Dis; 2016 Jan; 75(1):131-5. PubMed ID: 25261573
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of herpes zoster infection in patients with inflammatory bowel disease: a meta-analysis of cohort studies.
Ning L; Liu R; Li S; Shan G; Du H; Zhang J; Chen W; Zhang F; Yu J; Xu G
Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):219-227. PubMed ID: 31650411
[TBL] [Abstract][Full Text] [Related]
18. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
Lemaitre M; Kirchgesner J; Rudnichi A; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
JAMA; 2017 Nov; 318(17):1679-1686. PubMed ID: 29114832
[TBL] [Abstract][Full Text] [Related]
19. Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION).
Luu M; Benzenine E; Doret M; Michiels C; Barkun A; Degand T; Quantin C; Bardou M
Am J Gastroenterol; 2018 Nov; 113(11):1669-1677. PubMed ID: 29961771
[TBL] [Abstract][Full Text] [Related]
20. Incidence of herpes zoster in patients with inflammatory bowel disease.
Calm A; Calafat M; González-Muñoza C; Cañete F; Roig C; Mañosa M; García-Planella E; Domènech E
Gastroenterol Hepatol; 2024; 47(6):598-604. PubMed ID: 38316174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
